Vertex Pharmaceuticals

Vertex guns for virtual trials but hits pause, sees delays for 'some new study starts'
Vertex guns for virtual trials but hits pause, sees delays for 'some new study starts'
Fierce Biotech
Vertex Pharmaceuticals
COVID-19
clinical trials.
Flag link:
Who were biopharma's Q4 growth stars? Vertex, thanks to a new launch, plus Alexion, Regeneron and GSK
Who were biopharma's Q4 growth stars? Vertex, thanks to a new launch, plus Alexion, Regeneron and GSK
Fierce Pharma
Vertex Pharmaceuticals
Alexion
Regeneron
GSK
earnings
Flag link:
Pharmacquired: Where are all the deals?
Pharmacquired: Where are all the deals?
BioPharma Dive
M&A
Gilead Sciences
Biogen
Sanofi
Eli Lilly
GSK
Merck
Vertex Pharmaceuticals
Flag link:
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Motley Fool
beta thalassemia
rare disease
drug development
Acceleron
Bristol-Myers Squibb
Bluebird Bio
Sangamo Therapeutics
Vertex Pharmaceuticals
Editas Medicine
Syros Pharmaceuticals
Flag link:
What's in Store for Vertex in 2020 After a Remarkable 2019?
What's in Store for Vertex in 2020 After a Remarkable 2019?
Yahoo/Zacks.com
Vertex Pharmaceuticals
cystic fibrosis
Orkambi
Kalydeco
Symdeko
Trikafta
Flag link:
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
Stat
biotech
Jeff Leiden
Vertex Pharmaceuticals
Herb Boyer
Bob Swanson
Genentech
Amgen
George Rathmann
Gordon Binder
Flag link:
Vertex drops VX-961 to continue search for perfect pain drug
Vertex drops VX-961 to continue search for perfect pain drug
Fierce Biotech
Vertex Pharmaceuticals
VX-961
painkillers
Flag link:
Vertex impresses with strong Trikafta launch
Vertex impresses with strong Trikafta launch
BioPharma Dive
Vertex Pharmaceuticals
drug launches
cystic fibrosis
Trikafta
earnings
Flag link:
Are Biotech Stocks Due for a Correction in 2020?
Are Biotech Stocks Due for a Correction in 2020?
Motley Fool
biotech stocks
Axsome Therapeutics
Seattle Genetics
Vertex Pharmaceuticals
Flag link:
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
Endpoints
Vertex Pharmaceuticals
cystic fibrosis
JPMHC 2020
Gilead Sciences
M&A
Flag link:
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
JPMHC 2020
Bristol-Myers Squibb
Vertex Pharmaceuticals
Biomarin
Regeneron
Biogen
Alexion
Gilead Sciences
Amgen
Flag link:
The 4 biggest pharma market access stories of 2019
The 4 biggest pharma market access stories of 2019
Pharmaforum
biosimilars
UK
Orkambi
Vertex Pharmaceuticals
drug pricing
FDA
NICE
Flag link:
5 New Drug Approvals the FDA Gave Top Priority
5 New Drug Approvals the FDA Gave Top Priority
Motley Fool
FDA
drug approvals
Global Blood Therapeutics
Oxbryta
Alnylam
Givlaari
BeiGene
Brukinsa
Vertex Pharmaceuticals
Flag link:
FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
RAPS.org
FDA
Vertex Pharmaceuticals
Trikafta
Novartis
Adakveo
Alnylam
Givlaari
BeiGene
Brukinsa
Global Blood Therapeutics
Oxbryta
drug approvals
Flag link:
Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials
Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials
BioCentury
Vertex Pharmaceuticals
FDA
cystic fibrosis
Trikafta
Flag link:
A deal-hungry Vertex ushers in three more gene editing programs as it closes out harbinger CRISPR deal
A deal-hungry Vertex ushers in three more gene editing programs as it closes out harbinger CRISPR deal
Endpoints
Vertex Pharmaceuticals
CRISPR
gene editing
CTX001
Flag link:
After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines
After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines
Stat
Vertex Pharmaceuticals
cystic fibrosis
UK
Flag link:
‘A game-changer’: How Vertex delivered on cystic fibrosis
‘A game-changer’: How Vertex delivered on cystic fibrosis
Stat
Vertex Pharmaceuticals
cystic fibrosis
Trikafta
Flag link:
New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients
New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients
Stat
Vertex Pharmaceuticals
cystic fibrosis
FDA
Trikafta
Flag link:
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
Flag link:

Pages